Percutaneous Coronary Intervention

Procedural and Clinical Outcomes after Use of the Glycoprotein IIb/IIIa inhibitor Abciximab for Saphenous Vein Graft Interventions

October 30, 2015

Procedural and Clinical Outcomes after Use of the Glycoprotein IIb/IIIa inhibitor Abciximab for Saphenous Vein Graft Interventions, 30 oct, 2015, Cardiovascular Revascularization Medicine, Ralf E. Harskamp, Niels Hoedemaker, L. Kristin Newby, Pier Woudstra, Maik J. Grundeken, Marcel A. Beijk, Jan J. Piek, Jan G. Tijssen, Rajendra H. Mehta, Robbert J. de Winter Academic Medical Center – University of Amsterdam, Amsterdam, The Netherlands,VU University Medical Center, […]

tags in
, , , , ,

A Registry-Based Randomized Trial Comparing Radial and Femoral Approaches in Women Undergoing Percutaneous Coronary Intervention

August 12, 2014

A Registry-Based Randomized Trial Comparing Radial and Femoral Approaches in Women Undergoing Percutaneous Coronary Intervention J Am Coll Cardiol Intv. Aug 2014, Sunil V. Rao, MD∗; Connie N. Hess, MD, MHS∗; Britt Barham, BA∗; Laura H. Aberle, BSPH∗; Kevin J. Anstrom, PhD∗; Tejan B. Patel, MD†; Jesse P. Jorgensen, MD‡; Ernest L. Mazzaferri, MD§; Sanjit S. Jolly, […]

tags in
, , ,